These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30178304)

  • 1. B cells and antibody production in melanoma.
    Da Gama Duarte J; Peyper JM; Blackburn JM
    Mamm Genome; 2018 Dec; 29(11-12):790-805. PubMed ID: 30178304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodies.
    Gilbert AE; Karagiannis P; Dodev T; Koers A; Lacy K; Josephs DH; Takhar P; Geh JL; Healy C; Harries M; Acland KM; Rudman SM; Beavil RL; Blower PJ; Beavil AJ; Gould HJ; Spicer J; Nestle FO; Karagiannis SN
    PLoS One; 2011 Apr; 6(4):e19330. PubMed ID: 21559411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies.
    Willsmore ZN; Harris RJ; Crescioli S; Hussein K; Kakkassery H; Thapa D; Cheung A; Chauhan J; Bax HJ; Chenoweth A; Laddach R; Osborn G; McCraw A; Hoffmann RM; Nakamura M; Geh JL; MacKenzie-Ross A; Healy C; Tsoka S; Spicer JF; Papa S; Barber L; Lacy KE; Karagiannis SN
    Front Immunol; 2020; 11():622442. PubMed ID: 33569063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value.
    Kotlan B; Liszkay G; Blank M; Csuka O; Balatoni T; Toth L; Eles K; Horvath S; Naszados G; Olasz J; Banky B; Toth J; Godeny M; Marincola FM; Kasler M; Shoenfeld Y
    Immunol Res; 2015 Feb; 61(1-2):11-23. PubMed ID: 25480739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.
    De Wolf K; Kruse V; Sundahl N; van Gele M; Chevolet I; Speeckaert R; Brochez L; Ost P
    J Transl Med; 2017 Jan; 15(1):21. PubMed ID: 28137295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.
    Guy TV; Terry AM; Bolton HA; Hancock DG; Shklovskaya E; Fazekas de St. Groth B
    Cancer Immunol Immunother; 2016 Aug; 65(8):885-96. PubMed ID: 27222052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A B-cell or a key player? The different roles of B-cells and antibodies in melanoma.
    Rodgers CB; Mustard CJ; McLean RT; Hutchison S; Pritchard AL
    Pigment Cell Melanoma Res; 2022 May; 35(3):303-319. PubMed ID: 35218154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.
    Hsueh EC; Gupta RK; Qi K; Morton DL
    J Clin Oncol; 1998 Sep; 16(9):2913-20. PubMed ID: 9738558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity.
    Guy TV; Terry AM; Bolton HA; Hancock DG; Zhu E; Brink R; McGuire HM; Shklovskaya E; Fazekas de St. Groth B
    Oncotarget; 2016 May; 7(21):30211-29. PubMed ID: 27121060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment.
    Nishinaka Y; Ravindranath MH; Irie RF
    Cancer Res; 1996 Dec; 56(24):5666-71. PubMed ID: 8971173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer developments in the immunotherapy of malignant melanoma.
    Maslin B; Alexandrescu DT; Ichim TE; Dasanu CA
    J Oncol Pharm Pract; 2014 Feb; 20(1):3-10. PubMed ID: 23435643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?
    Siliņa K; Rulle U; Kalniņa Z; Linē A
    Cancer Immunol Immunother; 2014 Jul; 63(7):643-62. PubMed ID: 24695950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of metastatic melanoma: new immunomodulatory agents.
    Sznol M
    Semin Oncol; 2012 Apr; 39(2):192-203. PubMed ID: 22484191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into antigen encounter by B cells.
    Le Roux D; Niedergang F
    Immunobiology; 2012 Dec; 217(12):1285-91. PubMed ID: 22883562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein.
    Reisfeld RA; Gillies SD; Mendelsohn J; Varki NM; Becker JC
    Cancer Res; 1996 Apr; 56(8):1707-12. PubMed ID: 8620479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating B Cell Development, Natural and Primary Antibody Responses in Ly-6A/Sca-1 Deficient Mice.
    Jones MA; DeWolf S; Vacharathit V; Yim M; Spencer S; Bamezai AK
    PLoS One; 2016; 11(6):e0157271. PubMed ID: 27322740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
    Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
    Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of ABCB5 tumour antigen-specific CD8
    Borchers S; Maβlo C; Müller CA; Tahedl A; Volkind J; Nowak Y; Umansky V; Esterlechner J; Frank MH; Ganss C; Kluth MA; Utikal J
    Clin Exp Immunol; 2018 Jan; 191(1):74-83. PubMed ID: 28940439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.